JUVOROW Trademark

Trademark Overview

On Tuesday, July 23, 2019, a trademark application was filed for JUVOROW with the United States Patent and Trademark Office. The USPTO has given the JUVOROW trademark a serial number of 88530234. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 1, 2022. This trademark is owned by OWP Pharmaceuticals, Inc.. The JUVOROW trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of bipolar disorder, schizophrenia, and major depressive disorder
juvorow

General Information

Serial Number88530234
Word MarkJUVOROW
Filing DateTuesday, July 23, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of bipolar disorder, schizophrenia, and major depressive disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOWP Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNaperville, IL 60563
Party NameOWP Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNaperville, IL 60563

Trademark Events

Event DateEvent Description
Monday, August 1, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 1, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 28, 2021SOU EXTENSION 4 GRANTED
Tuesday, December 28, 2021SOU EXTENSION 4 FILED
Tuesday, December 28, 2021TEAS EXTENSION RECEIVED
Friday, July 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 30, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 30, 2021SOU EXTENSION 3 FILED
Wednesday, June 30, 2021TEAS EXTENSION RECEIVED
Thursday, April 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 28, 2021SOU EXTENSION 2 GRANTED
Thursday, December 31, 2020SOU EXTENSION 2 FILED
Wednesday, April 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 30, 2021NOTICE OF REVIVAL - E-MAILED
Monday, March 29, 2021EXTENSION RECEIVED WITH TEAS PETITION
Monday, March 29, 2021PETITION TO REVIVE-GRANTED
Monday, March 29, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, February 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 29, 2020SOU EXTENSION 1 GRANTED
Friday, May 29, 2020SOU EXTENSION 1 FILED
Friday, May 29, 2020TEAS EXTENSION RECEIVED
Wednesday, January 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 26, 2019ASSIGNED TO EXAMINER
Tuesday, September 24, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, July 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 26, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

juvorow disorder schizophrenia depressive major bipolar preparations treatment pharmaceutical